Genertec Universal Valuation

5UM Stock  EUR 0.58  0.01  1.75%   
Genertec Universal is fairly valued. Genertec Universal retains a regular Real Value of €0.57 per share. The prevalent price of the firm is €0.58. Our model calculates the value of Genertec Universal from evaluating the firm fundamentals such as Current Valuation of 7.33 B, return on equity of 0.12, and Return On Asset of 0.0283 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
0.58
Please note that Genertec Universal's price fluctuation is extremely dangerous at this time. Calculation of the real value of Genertec Universal is based on 3 months time horizon. Increasing Genertec Universal's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Genertec stock is determined by what a typical buyer is willing to pay for full or partial control of Genertec Universal Medical. Since Genertec Universal is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genertec Stock. However, Genertec Universal's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.58 Real  0.57 Hype  0.58 Naive  0.58
The real value of Genertec Stock, also known as its intrinsic value, is the underlying worth of Genertec Universal Company, which is reflected in its stock price. It is based on Genertec Universal's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Genertec Universal's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.57
Real Value
2.97
Upside
Estimating the potential upside or downside of Genertec Universal Medical helps investors to forecast how Genertec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genertec Universal more accurately as focusing exclusively on Genertec Universal's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.550.570.60
Details
Hype
Prediction
LowEstimatedHigh
0.030.582.98
Details
Naive
Forecast
LowNext ValueHigh
0.010.582.98
Details

Genertec Universal Total Value Analysis

Genertec Universal Medical is presently estimated to have takeover price of 7.33 B with market capitalization of 1.06 B, debt of 28.65 B, and cash on hands of 266.78 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Genertec Universal fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.33 B
1.06 B
28.65 B
266.78 M

Genertec Universal Investor Information

About 55.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 0.51. In the past many companies with similar price-to-book ratios have beat the market. Genertec Universal last dividend was issued on the 9th of June 2022. Genertec Universal Medical is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.

Genertec Universal Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Genertec Universal has an asset utilization ratio of 14.18 percent. This implies that the Company is making €0.14 for each dollar of assets. An increasing asset utilization means that Genertec Universal Medical is more efficient with each dollar of assets it utilizes for everyday operations.

Genertec Universal Ownership Allocation

Genertec Universal Medical has a total of 1.89 Billion outstanding shares. Genertec Universal secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Genertec Universal Profitability Analysis

The company reported the revenue of 9.91 B. Net Income was 1.95 B with profit before overhead, payroll, taxes, and interest of 3.85 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Genertec Universal's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Genertec Universal and how it compares across the competition.

About Genertec Universal Valuation

The stock valuation mechanism determines Genertec Universal's current worth on a weekly basis. Our valuation model uses a comparative analysis of Genertec Universal. We calculate exposure to Genertec Universal's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genertec Universal's related companies.
Genertec Universal Medical Group Company Limited provides integrated healthcare services with integration of capital, technology, equipment, specialists, management, and training resources to hospital customers in Mainland China and Hong Kong. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. GENERTEC UNIVER operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 705 people.

8 Steps to conduct Genertec Universal's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Genertec Universal's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Genertec Universal's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Genertec Universal's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Genertec Universal's revenue streams: Identify Genertec Universal's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Genertec Universal's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Genertec Universal's growth potential: Evaluate Genertec Universal's management, business model, and growth potential.
  • Determine Genertec Universal's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Genertec Universal's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Genertec Stock analysis

When running Genertec Universal's price analysis, check to measure Genertec Universal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genertec Universal is operating at the current time. Most of Genertec Universal's value examination focuses on studying past and present price action to predict the probability of Genertec Universal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genertec Universal's price. Additionally, you may evaluate how the addition of Genertec Universal to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites